Bob McWhirterJust a reminder that the only analyst who has ever commented on SVA is back on Market Call later today. Below are his previous comments. GLTA
BUY
Sernova Corp.
(SVA-X)
January 5, 2021
Disclosure: He's helped with 2-3 of their financings recently. They make a credit-card sized pouch inserted under the skin that produces insulin to reduce extreme high or low insulin levels. That pouch can be used for many other applications in the future. Results are coming soon. SVA has broken out from 30 cents to 70 before the reports. There are strong opportunities for them in the coming year with potential deals with drugmakers and distributors.
Robert McWhirter
Price
$0.670
Owned
Yes